NeuroSense Therapeutics Statistics

Total Valuation

NRSN has a market cap or net worth of $26.77 million. The enterprise value is $26.78 million.

Market Cap	26.77M
Enterprise Value	26.78M

Important Dates

The next estimated earnings date is Friday, July 31, 2026, before market open.

Earnings Date	Jul 31, 2026
Ex-Dividend Date	n/a

Share Statistics

NRSN has 35.35 million shares outstanding. The number of shares has increased by 36.98% in one year.

Current Share Class	35.35M
Shares Outstanding	35.35M
Shares Change (YoY)	+36.98%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	40.48%
Owned by Institutions (%)	1.12%
Float	21.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	25.00
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.31

Current Ratio	0.31
Quick Ratio	0.08
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -2,174.98% and return on invested capital (ROIC) is -1,094.49%.

Return on Equity (ROE)	-2,174.98%
Return on Assets (ROA)	-247.30%
Return on Invested Capital (ROIC)	-1,094.49%
Return on Capital Employed (ROCE)	744.96%
Weighted Average Cost of Capital (WACC)	12.64%
Revenue Per Employee	n/a
Profits Per Employee	-$654,412
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.57% in the last 52 weeks. The beta is 1.54, so NRSN's price volatility has been higher than the market average.

Beta (5Y)	1.54
52-Week Price Change	-65.57%
50-Day Moving Average	0.79
200-Day Moving Average	0.94
Relative Strength Index (RSI)	47.53
Average Volume (20 Days)	162,064

Short Selling Information

The latest short interest is 491,665, so 1.39% of the outstanding shares have been sold short.

Short Interest	491,665
Short Previous Month	369,629
Short % of Shares Out	1.39%
Short % of Float	2.34%
Short Ratio (days to cover)	3.66

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-11.09M
Pretax Income	-11.13M
Net Income	-11.13M
EBITDA	-11.07M
EBIT	-11.09M
Earnings Per Share (EPS)	-$0.44

Full Income Statement

Balance Sheet

The company has $166,000 in cash and $170,000 in debt, giving a net cash position of -$4,000 or -$0.00 per share.

Cash & Cash Equivalents	166,000
Total Debt	170,000
Net Cash	-4,000
Net Cash Per Share	-$0.00
Equity (Book Value)	-1.56M
Book Value Per Share	-0.05
Working Capital	-1.74M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.67 million and capital expenditures -$8,000, giving a free cash flow of -$7.68 million.

Operating Cash Flow	-7.67M
Capital Expenditures	-8,000
Depreciation & Amortization	16,000
Net Borrowing	n/a
Free Cash Flow	-7.68M
FCF Per Share	-$0.22

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NRSN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.98%
Shareholder Yield	-36.98%
Earnings Yield	-41.55%
FCF Yield	-28.68%

Analyst Forecast

The average price target for NRSN is $6.50, which is 758.20% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.50
Price Target Difference	758.20%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1